Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant

Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant

The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide adjuvant comprises of a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic and at least on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lin, Haixiang, Li, Lie Tao Victor
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Lin, Haixiang
Li, Lie Tao Victor
description The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide adjuvant comprises of a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic and at least one positive ion. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine) selected from viral, bacterial, fungal, parasitic and/or cancer antigens. The present invention further contemplates methods of use of such adjuvant compositions, particularly in eliciting an immune response, in particular a mucosal immune response to an antigenic compound.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08303966</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08303966</sourcerecordid><originalsourceid>FETCH-uspatents_grants_083039663</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHPxINU_7AcKhUDRsyh6FzzKNolhJdmEblLo722hD_A0zDB79XrEWDl5x2RA6iAF2TgBk2IeSYg9IOQUZuK02DKhIduuxcyFLIUtwYDiLKD91gm5HNTug0HccWOj4HZ9Xu5tlYzFcZG3H3FFd9KdPve9_mP5AaFlO9E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant</title><source>USPTO Issued Patents</source><creator>Lin, Haixiang ; Li, Lie Tao Victor</creator><creatorcontrib>Lin, Haixiang ; Li, Lie Tao Victor ; Yisheng Biopharma (Singapore) Pte. Ltd</creatorcontrib><description>The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide adjuvant comprises of a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic and at least one positive ion. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine) selected from viral, bacterial, fungal, parasitic and/or cancer antigens. The present invention further contemplates methods of use of such adjuvant compositions, particularly in eliciting an immune response, in particular a mucosal immune response to an antigenic compound.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8303966$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8303966$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lin, Haixiang</creatorcontrib><creatorcontrib>Li, Lie Tao Victor</creatorcontrib><creatorcontrib>Yisheng Biopharma (Singapore) Pte. Ltd</creatorcontrib><title>Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant</title><description>The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide adjuvant comprises of a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic and at least one positive ion. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine) selected from viral, bacterial, fungal, parasitic and/or cancer antigens. The present invention further contemplates methods of use of such adjuvant compositions, particularly in eliciting an immune response, in particular a mucosal immune response to an antigenic compound.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNikEKwjAQAHPxINU_7AcKhUDRsyh6FzzKNolhJdmEblLo722hD_A0zDB79XrEWDl5x2RA6iAF2TgBk2IeSYg9IOQUZuK02DKhIduuxcyFLIUtwYDiLKD91gm5HNTug0HccWOj4HZ9Xu5tlYzFcZG3H3FFd9KdPve9_mP5AaFlO9E</recordid><startdate>20121106</startdate><enddate>20121106</enddate><creator>Lin, Haixiang</creator><creator>Li, Lie Tao Victor</creator><scope>EFH</scope></search><sort><creationdate>20121106</creationdate><title>Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant</title><author>Lin, Haixiang ; Li, Lie Tao Victor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_083039663</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Lin, Haixiang</creatorcontrib><creatorcontrib>Li, Lie Tao Victor</creatorcontrib><creatorcontrib>Yisheng Biopharma (Singapore) Pte. Ltd</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lin, Haixiang</au><au>Li, Lie Tao Victor</au><aucorp>Yisheng Biopharma (Singapore) Pte. Ltd</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant</title><date>2012-11-06</date><risdate>2012</risdate><abstract>The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide adjuvant comprises of a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic and at least one positive ion. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine) selected from viral, bacterial, fungal, parasitic and/or cancer antigens. The present invention further contemplates methods of use of such adjuvant compositions, particularly in eliciting an immune response, in particular a mucosal immune response to an antigenic compound.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08303966
source USPTO Issued Patents
title Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A59%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Lin,%20Haixiang&rft.aucorp=Yisheng%20Biopharma%20(Singapore)%20Pte.%20Ltd&rft.date=2012-11-06&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08303966%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true